Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intrathecal Dexmedetomidine in Elderly TURP Patients
NCT05351489Phase 1Completed
- Sponsor
- Mansoura University
- Start
- May 2022
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dexmedetomidine in benign prostatic hyperplasia (BPH) (2 arms), sponsored by Mansoura University. Primary endpoint: Duration of analgesia at 24 hours. Started May 2022; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT05351489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05351489.